%201.png)
The Challenge:
Restoring Microbiome Balance
Modern diets, stress, antibiotics, and environmental exposures disrupt the gut’s microbial equilibrium, driving chronic inflammation and metabolic imbalance. This state of dysbiosis affects not only digestion but also immune function, energy metabolism, cognition, and long-term disease risk.
The microbiome is now recognized as a central regulator of human biology — influencing metabolism, immunity, mood, and cognitive performance.
Most traditional probiotics and supplements are limited by fragility, dependence on survival and colonization, lack of precision, modest potency, affordability, and insufficient scientific validation.
Emerging science suggests that restoring balance to the microbiome through postbiotics can help address these challenges.


%201.png)


%201.png)

%201.png)
.avif)
We begin by fermenting with a strain from our portfolio of human-derived strains — we work exclusively with human-derived strains.
A first fermentation cycle creates a postbiotic-rich solution that becomes the matrix for all subsequent steps in the platform.
.avif)
After a first cycle, the postbiotic composition is deactivated and carried forward intact as a whole, without removing or separating any components.
This intact solution becomes the substrate for the next fermentation cycle.
.avif)
Each fermentation cycle builds on the previous one, increasing the diversity and biological activity of the final composition.
By adjusting simple parameters, we can guide the process toward specific health targets such as immunity, gut balance, metabolic support, skin health, or recovery.The end result is a stable, neutral-tasting powder that is measurable, reproducible, and scalable for global manufacturing.
SciencePower originated in prevention and consumer health and is now expanding into oncology. Breakthrough preclinical breast-cancer findings have demonstrated measurable and statistically significant effects, forming the foundation for a new clinical development pathway.
These results provide the scientific basis for our oncology initiative and planned clinical trials, underscoring postbiotics as an emerging class of microbiome-based innovation with relevance in supportive care and broader therapeutic research.